| 01/09/26 | STX | 07:00:14 | 1 Sept 2026 | | STX | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 27/08/26 | STX | 16:00:00 | 27 Aug 2026 | | STX | Shield assumes full control of ACCRUFeR® in the US | Shield Therapeutics PLC | RNS |
| 20/08/26 | STX | 07:00:06 | 20 Aug 2026 | | STX | Interim results for the six months ended 30 Jun 26 | Shield Therapeutics PLC | RNS |
| 03/08/26 | STX | 12:02:21 | 3 Aug 2026 | | STX | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 30/07/26 | STX | 07:00:04 | 30 Jul 2026 | | STX | Q2 and H1 2026 Trading Update | Shield Therapeutics PLC | RNS |
| 28/07/26 | STX | 07:00:06 | 28 Jul 2026 | | STX | ACCRUFeR® Phase 3 pediatric trial published | Shield Therapeutics PLC | RNS |
| 30/06/26 | STX | 07:52:15 | 30 Jun 2026 | | STX | Block Listing 6 Monthly Return | Shield Therapeutics PLC | RNS |
| 18/06/26 | STX | 16:20:59 | 18 Jun 2026 | | STX | Results of 2026 Annual General Meeting | Shield Therapeutics PLC | RNS |
| 29/05/26 | STX | 09:11:15 | 29 May 2026 | | STX | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 05/05/26 | STX | 07:00:13 | 5 May 2026 | | STX | Grant of Share Options | Shield Therapeutics PLC | RNS |
| 01/05/26 | STX | 07:00:05 | 1 May 2026 | | STX | Q1 2026 Trading Update | Shield Therapeutics PLC | RNS |
| 30/04/26 | STX | 07:01:01 | 30 Apr 2026 | | STX | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 27/04/26 | STX | 07:00:10 | 27 Apr 2026 | | STX | Enrollment in Phase II Clinical Trial for ACCRUFeR | Shield Therapeutics PLC | RNS |
| 09/04/26 | STX | 12:30:28 | 9 Apr 2026 | | STX | Audited results for year ended 31 December 2025 | Shield Therapeutics PLC | RNS |
| 01/04/26 | STX | 09:22:08 | 1 Apr 2026 | | STX | Publication of Report, Reinforcing FDA Approval | Shield Therapeutics PLC | RNS |
| 31/03/26 | STX | 07:03:00 | 31 Mar 2026 | | STX | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 31/03/26 | STX | 07:00:14 | 31 Mar 2026 | | STX | EMA approves extension - to include adolescents | Shield Therapeutics PLC | RNS |
| 03/03/26 | STX | 07:00:10 | 3 Mar 2026 | | STX | Chinese NMPA Accepts MAA Submission for ACCRUFeR® | Shield Therapeutics PLC | RNS |
| 27/02/26 | STX | 07:00:09 | 27 Feb 2026 | | STX | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 09/02/26 | STX | 07:00:10 | 9 Feb 2026 | | STX | FDA Grants additional Exclusivity for ACCRUFeR | Shield Therapeutics PLC | RNS |
| 30/01/26 | STX | 07:05:00 | 30 Jan 2026 | | STX | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 30/01/26 | STX | 07:00:09 | 30 Jan 2026 | | STX | Approval for ACCRUFeR in China expected in Q1 2026 | Shield Therapeutics PLC | RNS |
| 21/01/26 | STX | 07:00:08 | 21 Jan 2026 | | STX | Q4 2025 Trading Update | Shield Therapeutics PLC | RNS |
| 02/01/26 | STX | 11:06:43 | 2 Jan 2026 | | STX | Block listing 6 Monthly Return | Shield Therapeutics PLC | RNS |
| 02/01/26 | STX | 07:00:02 | 2 Jan 2026 | | STX | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 22/12/25 | STX | 07:00:07 | 22 Dec 2025 | | STX | FDA approves extension for ACCRUFeR® | Shield Therapeutics PLC | RNS |
| 18/12/25 | STX | 07:13:12 | 18 Dec 2025 | | STX | Block Listing Application | Shield Therapeutics PLC | RNS |
| 11/12/25 | STX | 07:00:09 | 11 Dec 2025 | | STX | Shield Wins Gold at Titan Branding Awards | Shield Therapeutics PLC | RNS |
| 03/12/25 | STX | 07:04:17 | 3 Dec 2025 | | STX | Amends Senior Secured Debt Financing | Shield Therapeutics PLC | RNS |
| 14/11/25 | STX | 07:03:37 | 14 Nov 2025 | | STX | Initiation of a Phase II Clinical Trial in Japan | Shield Therapeutics PLC | RNS |
| 11/11/25 | STX | 07:00:10 | 11 Nov 2025 | | STX | ACCRUFeR Pediatric PK Results to be Presented | Shield Therapeutics PLC | RNS |
| 07/11/25 | STX | 07:03:57 | 7 Nov 2025 | | STX | ACCRUFeR receives Authorisation by Korean Ministry | Shield Therapeutics PLC | RNS |
| 23/10/25 | STX | 07:00:01 | 23 Oct 2025 | | STX | Q3 2025 Trading Update | Shield Therapeutics PLC | RNS |
| 14/10/25 | STX | 15:01:57 | 14 Oct 2025 | | STX | Grant of Share Options to Chief Executive Officer | Shield Therapeutics PLC | RNS |
| 01/10/25 | STX | 08:00:00 | 1 Oct 2025 | | STX | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 01/10/25 | STX | 07:02:00 | 1 Oct 2025 | | STX | Positive efficacy and tolerance in pediatric trial | Shield Therapeutics PLC | RNS |
| 15/09/25 | STX | 07:00:10 | 15 Sept 2025 | | STX | £1.5 million placing supporting growth of ACCRUFeR | Shield Therapeutics PLC | RNS |
| 04/09/25 | STX | 07:03:00 | 4 Sept 2025 | | STX | ACCRUFeR® assigned Priority Review in US by FDA | Shield Therapeutics PLC | RNS |
| 03/09/25 | STX | 14:17:48 | 3 Sept 2025 | | STX | Interim results for the six months ended 30 Jun 25 | Shield Therapeutics PLC | RNS |
| 27/08/25 | STX | 07:13:24 | 27 Aug 2025 | | STX | Data published -European Journal of Heart Failure | Shield Therapeutics PLC | RNS |
| 21/08/25 | STX | 12:06:01 | 21 Aug 2025 | | STX | Interim results for the six months ended 30 Jun 25 | Shield Therapeutics PLC | RNS |
| 23/07/25 | STX | 07:00:01 | 23 Jul 2025 | | STX | Q2 2025 Trading Update | Shield Therapeutics PLC | RNS |
| 22/05/25 | STX | 17:06:33 | 22 May 2025 | | STX | Result of AGM | Shield Therapeutics PLC | RNS |
| 24/04/25 | STX | 07:06:52 | 24 Apr 2025 | | STX | Audited results for the year ended 31 Dec 2024 | Shield Therapeutics PLC | RNS |
| 22/04/25 | STX | 07:01:15 | 22 Apr 2025 | | STX | Licence Agreement in Japan for ACCRUFeR® | Shield Therapeutics PLC | RNS |
| 17/04/25 | STX | 11:23:02 | 17 Apr 2025 | | STX | Q1 2025 Trading Update | Shield Therapeutics PLC | RNS |
| 11/03/25 | STX | 07:00:05 | 11 Mar 2025 | | STX | ACCRUFeR® launched in Canada | Shield Therapeutics PLC | RNS |
| 13/02/25 | STX | 16:15:00 | 13 Feb 2025 | | STX | PDMR Transaction Notification | Shield Therapeutics PLC | RNS |
| 13/02/25 | STX | 07:00:08 | 13 Feb 2025 | | STX | Grant of Share Options | Shield Therapeutics PLC | RNS |
| 05/02/25 | STX | 07:00:01 | 5 Feb 2025 | | STX | Unaudited full year trading update | Shield Therapeutics PLC | RNS |
